The Food and Drug Administration (FDA or the Agency) is issuing an order under the Federal Food, Drug, and Cosmetic Act (FD&C Act) permanently debarring Angela Anatilde Baquero from providing services in any capacity to a person that has an approved or pending drug product application. FDA bases this order on a finding that Angela Anatilde Baquero was convicted of a felony under Federal law for conduct relating to the development or approval, including the process for development or approval, of any drug product. Mrs. Baquero was given notice of the proposed debarment and an opportunity to request a hearing within the timeframe prescribed by regulation. As of May 6, 2026 (30 days after receipt of the notice), Mrs. Baquero has not responded. Mrs. Baquero's failure to respond and request a hearing constitutes a waiver of Mrs. Baquero's right to a hearing concerning this matter.
US Federal Register - FDA Notices · August 03, 2026
Angela Anatilde Baquero: Final Debarment Order
FDA permanently debars Angela Anatilde Baquero from providing services to persons with approved or pending drug product applications following felony conviction.
Applies from
2026-05-06
Published by US Federal Register - FDA Notices. HealthSignal links to the original document; the summary above is extracted from the source text.